Regenerative Treatment for Diabetic ED: Questions to Ask Before You Decide
Considering regenerative treatment for diabetic ED? Learn what the evidence covers, six questions to ask a clinic, and how Nordic Stem Cell answers them.
Jon Plate
Author
Living with diabetes and erectile dysfunction (ED) for years usually means a long series of adjustments: different doses, different medications, and a growing sense that the options are running out. A regenerative treatment can bring real hope in that situation, and it can also bring confusion, because clinics don't all describe the evidence in the same way.
This guide explains what regenerative treatment is, what the evidence covers for men with diabetes, six questions worth putting to any clinic, the red flags that matter, and how Nordic Stem Cell answers the same questions.
What Is Regenerative Treatment for Diabetic Erectile Dysfunction?
Regenerative treatment uses a man's own stem cells, injected into the erectile tissue, to act on the nerves and blood vessels that erections depend on, both of which diabetes damages over time. ED medication supports an erection while it is active, and regenerative treatment acts on the tissue itself. The evidence in men with diabetes is still early, which is why the questions below matter.
How Diabetes Damages the Nerves and Blood Vessels Behind Erections
Years of high blood sugar injure the small blood vessels and the nerves, and the nerve damage is called diabetic neuropathy. The vessel lining also produces less nitric oxide, the molecule that tells the vessels to widen and let blood in. ED is common in this situation: the endocrinology reference Endotext puts its prevalence at about 52.5% among men with diabetes, roughly 3.5 times the rate in men without it. A 2009 review in Diabetes Care reports that ED medication works in about 70 to 89% of men in the general population, compared with just over 50% of men with diabetes and ED.
What Regenerative Treatment Acts On
Regenerative treatment acts on two processes: neuroregeneration, the repair of damaged nerve tissue, and angiogenesis, the formation of new blood vessels. Those are the same two systems diabetes affects over time. The mechanism is what makes the approach relevant to diabetic ED.
Does Stem Cell Therapy Work for Diabetic ED?
The Nordic Method comes from a Phase 1 clinical trial at Odense University Hospital in Denmark (Haahr et al.), approved by the Danish Medicines Agency and registered as NCT02240823. It studied 17 men with severe ED after radical prostatectomy, the surgery that removes the prostate, and the results were published in EBioMedicine in 2016, with a 12-month follow-up in Urology in 2018.
Diabetes wasn't the condition studied, so there is no diabetes-specific outcome data for the Nordic Method yet. However, the mechanism matches the kind of damage diabetes causes, and Nordic Stem Cell offers the Nordic Method to men with diabetes-related ED.
What Questions Should You Ask a Clinic Before Regenerative ED Treatment?
Six questions cover most of what separates a transparent clinic from a vague one. The table below shows why each matters and what a credible answer sounds like.
| Question | Why it matters | What a credible answer sounds like |
|---|---|---|
| Whose trial data are you citing, and does it include men with diabetes? | Results from one group, such as men after prostate surgery, don't automatically apply to another. | The clinic names the group behind each statistic and says plainly when men with diabetes weren't included. |
| Which cells and protocol do you use, and is that the protocol that was studied? | Cell source, dose, and number of injections vary between clinics, so one protocol's results don't carry over to another. | The clinic describes its own cells, procedure, and trial, without borrowing results from a different approach. |
| What are your eligibility criteria for a man with diabetes? | Diabetes duration, blood sugar control (measured by HbA1c), existing nerve or vessel damage, and earlier treatments can all change the outlook. | Specific criteria, an individual evaluation, and a willingness to advise against treatment. |
| How do you measure success, and over what timeline? | Without a defined measure, favorable results can be reported while unfavorable ones go unnoticed. | A recognized score such as the IIEF-5 (a five-question survey doctors use to rate ED), scheduled follow-up, and a stated timeline. |
| What are the risks for a man with diabetes? | Diabetes affects infection risk and healing, and the fat-collection step involves anesthesia. | An explanation of screening, blood sugar targets before the procedure, and hospital-level care. |
| What happens if the treatment doesn't produce the result I hoped for? | A clinic's plan for a disappointing outcome shows how it treats patients after the procedure. | A defined follow-up process, further evaluation, and a straightforward discussion of next steps. |
What Red Flags Should You Watch For When Choosing a Clinic?
Certain patterns tend to signal a clinic that is selling more than the evidence supports:
- Success rates are quoted without saying which patient group they come from.
- Testimonials and before-and-after stories stand in for a measurement standard.
- Eligibility sounds the same for everyone, with no real screening.
- The clinic guarantees results or avoids discussing where the evidence ends.
- The setting and language resemble a wellness spa more than a medical facility.
- No plan exists for what happens if treatment doesn't work.
A clinic that says "we don't have that data yet" on a given point is often showing the transparency a man is hoping to find.
How Does Nordic Stem Cell Answer These Questions?
Nordic Stem Cell can be held to the same six questions.
What the Treatment Involves
The Nordic Method uses a patient's own fat-derived stem cells, so no donor tissue is involved. About 400 g of fat is collected under general anesthesia at CIMA Hospital, which is accredited by Joint Commission International (JCI), and the cells are processed and injected the same day at the clinic in the same compound, with nothing stored or banked. The treatment takes about six hours, and the whole trip to Costa Rica takes about three days, including travel. Nordic Stem Cell is the first licensed clinic to offer this protocol outside a clinical trial. Costa Rica permits adult procedures that use a patient's own cells, which is why the treatment is offered there, while regenerative cell treatments for ED aren't widely available as standard care in the United States.
How Men With Diabetes Are Evaluated
Each man with diabetes is evaluated individually, and eligibility is assessed case by case. Screening includes a detailed medical history, cardiovascular screening, and lab work, and blood sugar control is part of that review. Nordic Stem Cell doesn't treat men with active cancer or certain serious heart conditions.
How Results Are Tracked
Results build gradually, typically over four to six months, as new blood vessels form and nerves recover. Follow-up consultations take place at 3, 6, and 9 months; progress is tracked with the IIEF-5 score, and a nocturnal erection monitoring device for home use is included in the treatment price.
For men who want to see how the mechanism applies to diabetes or whether their own case might fit, Nordic Stem Cell offers a free, confidential eligibility check with no obligation.
Summary
Choosing regenerative treatment for diabetic ED comes down to six questions: whose trial data is being cited, which cells and protocol are used, what the eligibility criteria are for a man with diabetes, how success is measured, what the risks are, and what happens if the result falls short. The Nordic Method's trial studied men after prostatectomy; no diabetes-specific outcome data exists for it yet, and the mechanism it acts on matches the damage diabetes causes. A clinic that answers each question plainly, including where the evidence ends, deserves more trust than one offering confident promises.
Frequently Asked Questions
Find answers to common questions about this topic. Click on any question to reveal the answer.
Not yet for the Nordic Method. Its trial studied men with ED after prostate surgery, and no diabetes-specific outcome data exists for it. The mechanism it acts on is relevant to diabetes, and Nordic Stem Cell is building the evidence base for that group.
It can be a factor. Blood sugar control affects both the extent of nerve and vessel damage and the risks of the fat-collection step, so it is part of each man's evaluation. For elective surgery, the American Diabetes Association suggests an A1C goal below 8% whenever possible.
Common signs include success rates that aren't tied to a stated patient group, testimonials in place of a measurement standard, and reluctance to say whose data a number comes from. A clinic that names the group behind each statistic and acknowledges what isn't yet known is generally more transparent.
Diabetes can raise the risk of infection and slow healing after any procedure, and the ADA notes that the stress of surgery can raise blood sugar. Screening, blood sugar targets before the procedure, and a hospital setting address those concerns, and each man's risk is assessed individually.
Different approaches use different cell sources, such as fat, bone marrow, or umbilical cord blood. The Nordic Method uses the patient's own fat-derived cells, so no donor tissue is involved, and the cells are processed and injected the same day.
Results build gradually, typically over four to six months, as new blood vessels form and nerves recover. Follow-up consultations at 3, 6, and 9 months track progress with the IIEF-5 score. Response varies from man to man.
It isn't widely available as standard care in the United States, largely because of regulation. Costa Rica permits adult procedures that use a patient's own cells, which is why Nordic Stem Cell offers the Nordic Method in San José, and patients travel there from the United States and elsewhere.
It is worth treating as information. A clinic confident in its evidence and its process can usually explain whose data it cites, how it screens patients, and what happens if results fall short, including where the data doesn't yet exist.
Jon Plate
COO at Nordic Stem Cell
Leading operations, team development, and clinical execution for a regenerative medicine clinic focused on stem cell–based treatment for erectile dysfunction, particularly following prostate cancer surgery. Partner closely with medical leadership to scale a peer-reviewed clinical protocol into a responsible, patient-centered care model. Oversee organizational growth, clinical operations, and cross-functional teams to ensure consistency, quality, and long-term sustainability.
Complete a short confidential assessment and speak with a medical specialist about your options.
Free Eligibility Check